Intervertebral Disc Displacement Clinical Trial
Official title:
Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions
Verified date | January 2017 |
Source | ZetrOZ, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
ZetrOZ's Ultrasonic Diathermy device is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatment of muscle spasm and joint contracture, and increasing local circulation. This study will look at the use of therapeutic ultrasound to relieve pain and reduce disability in subjects with chronic low back pain, a subset of which will have chronic low back pain due to a herniated disc, over an 8-week treatment period.
Status | Completed |
Enrollment | 65 |
Est. completion date | April 2016 |
Est. primary completion date | April 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of Chronic low back pain, may be secondary to herniated nucleus pulposus (HNP) or other causes - 18-60 years of age, inclusive - Has Numeric Rating Scale (NRS) pain severity score of at least 4 for a minimum 5 days over the 1 week Baseline Period prior to being randomized to treatment - Pain lasting >3 months - Has MRI from within 2 months prior to Screening (If no recent MRI is available, then subject must agree to have MRI performed prior to randomization of treatment) - If pain is secondary to HNP: MRI within the last 2 months demonstrating the presence of a herniated disc; herniated disc is laterally located and not centrally located; herniated disc is not sequestered - Has the presence of radicular pain as assessed by a health care practitioner - Is willing and able to self-administer treatment daily within their place of residence or during normal daily activity, excluding bathing, showering, or other water activities which may result in submersion of the study device. - Is maintained on a stable pain management regimen, which may include opioid and/or non-opioid analgesic medications, but must be willing to keep dosage(s) stable through the study period; any dose adjustments that the investigator feels are required during the study period must be discussed with the study sponsor; and the use of any medications must be documented in the subject's Medication Log. - Be willing to discontinue any other interventional treatment modalities on the lower back during the study period (e.g., transcutaneous electrical nerve stimulation, electronic muscle stimulation, traditional ultrasound). Exclusion Criteria: - Cannot successfully demonstrate the ability to put on and take off the device. - Displays any condition which, in the judgment of the investigator, would make participation in the study unacceptable including, but not limited to, the subject's ability to understand and follow instructions. - Participated in a clinical trial for an investigational drug and/or agent within 30 days prior to screening. - Has arthritis, bone spurs, stenosis, fusions, or implants near the treatment area. - Is pregnant. - Is a prisoner. - Is non-ambulatory (unable to walk). - Has a pacemaker. - Has a malignancy in the treatment area. - Has an active infection, open sores, or wounds in the treatment area. - Has impaired sensation in the treatment area, such as caused by chemotherapy or anesthesia. - Has a known neuropathy (disease of the brain or spinal nerves). - Has a hereditary disposition (tendency) for excessive bleeding (hemorrhage). - Has peripheral artery disease. - Has BMI =30 |
Country | Name | City | State |
---|---|---|---|
United States | Osteopathic Medical Arts | Chapel Hill | North Carolina |
United States | Medical Pain Consultants | Dryden | New York |
United States | Weber State University | Ogden | Utah |
Lead Sponsor | Collaborator |
---|---|
ZetrOZ, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Brief Pain Inventory-Short Form (BPI-SF): Pain Severity | Change from Baseline to Week 8 | ||
Secondary | BPI-SF: Pain Interference | Change from Baseline to Week 8 | ||
Secondary | Oswestry Disability Index | Change from Baseline to Week 8 | ||
Secondary | Numeric Rating Scale: Pain on Flexion | Change from Baseline to Week 8 | ||
Secondary | Numeric Rating Scale: Pain on Extension | Change from Baseline to Week 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02384928 -
Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation
|
N/A | |
Recruiting |
NCT04538807 -
EMG Finding According to the Type of Lumbar Disc Herniation
|
||
Terminated |
NCT00095095 -
Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device
|
Phase 4 | |
Withdrawn |
NCT02196883 -
Steroid Injections Given at the "Level of MRI Pathology" Versus at the "Level of Clinical Symptoms" to See if One is More Effective Than the Other.
|
N/A | |
Recruiting |
NCT01014520 -
Efficacy of Gabapentin or Amitriptyline to Reduce Postoperative Pain After Lumbar Laminectomy and Diskectomy
|
Phase 2 | |
Enrolling by invitation |
NCT05110833 -
Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
|
||
Completed |
NCT03750591 -
Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Inpatients With Sciatica Due to Lumbar Intervertebral Disc Herniation
|
||
Completed |
NCT03426215 -
Long-Term Course of Korean Medicine Treatment for Lumbar Disc Herniation
|
||
Active, not recruiting |
NCT03959098 -
Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation
|
||
Recruiting |
NCT02936739 -
Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Prosthesis Rotaio (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse
|
N/A | |
Recruiting |
NCT02936765 -
Comparison of Software-assisted Implantation of Elastic Spine Pad (TM) With Respect to Postoperative Change in Neck Disability Index (NDI) With the Conventional Disc Spacer Squale (TM) After Anterior Cervical Discectomy for Cervical Disc Prolapse
|
N/A | |
Completed |
NCT03571503 -
The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for HLD With Radiating Leg Pain
|
||
Completed |
NCT01922063 -
Physiotherapy Following Disc Surgery: Long Term Follow-up of a RCT
|
Phase 3 | |
Enrolling by invitation |
NCT05098431 -
Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
|
N/A | |
Completed |
NCT05022121 -
Integrated Supported Biopsychosocial Self-Management for Back Related Leg Pain
|
N/A | |
Completed |
NCT02889484 -
Outcome of Surgery for Sciatica - a Comparison of Data From Three National Quality Registries
|
N/A | |
Completed |
NCT02351206 -
Lumbar Disc Space Height in Young Disc Herniation and Degeneration Patients
|
||
Completed |
NCT05753579 -
Is Regression Possible in Lumbal Disc Herniation With Spinal Mobilization Applications?
|
N/A | |
Completed |
NCT05804357 -
The Effect of Manual Therapy on Psychological Factors and Quality of Life in Lumbal Disc Herniation Patients
|
N/A | |
Not yet recruiting |
NCT03011866 -
Tranexamic Acid in Reducing Gross Hemorrhage and Transfusions of Spine Surgeries
|
N/A |